Interactions of Alginate-Deferoxamine Conjugates With Blood Components and Their Antioxidation in the Hemoglobin Oxidation Model

While deferoxamine (DFO) has long been used as an FDA-approved iron chelator, its proangiogenesis ability attracts increasing number of research interests. To address its drawbacks such as short plasma half-life and toxicity, polymeric conjugated strategy has been proposed and shown superiority. Owi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Bioeng Biotechnol
Main Authors: Sun, Tong, Guo, Xi, Zhong, Rui, Wang, Chengwei, Liu, Hao, Li, Hao, Ma, Lu, Guan, Junwen, You, Chao, Tian, Meng
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Bioengineering and Biotechnology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7026261/
https://ncbi.nlm.nih.gov/pubmed/32117933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00053
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados